15.59
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.40
Offen:
$15.41
24-Stunden-Volumen:
47,738
Relative Volume:
0.04
Marktkapitalisierung:
$716.65M
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-155.85
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
-3.41%
1M Leistung:
+13.63%
6M Leistung:
-14.39%
1J Leistung:
+17.66%
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AXGN
Axogen Inc
|
15.57 | 708.59M | 203.27M | -4.66M | 3.47M | -0.10 |
![]()
ABT
Abbott Laboratories
|
133.24 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
107.34 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
392.30 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
93.08 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
80.96 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-17 | Eingeleitet | Lake Street | Buy |
2024-07-01 | Eingeleitet | Raymond James | Outperform |
2022-11-11 | Fortgesetzt | Jefferies | Buy |
2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2020-10-23 | Eingeleitet | Guggenheim | Buy |
2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
2018-03-02 | Bestätigt | Lake Street | Buy |
2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2017-11-30 | Eingeleitet | Jefferies | Buy |
2017-11-21 | Bestätigt | Lake Street | Buy |
2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2017-03-06 | Eingeleitet | ROTH Capital | Buy |
2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
2016-11-07 | Bestätigt | Wedbush | Outperform |
2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
2016-08-04 | Bestätigt | Wedbush | Outperform |
2014-05-14 | Eingeleitet | Dawson James | Buy |
2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Statistical indicators supporting Axogen Inc.’s strengthJuly 2025 Decliners & Weekly Market Pulse Updates - Newser
Top chart patterns to watch in Axogen Inc.Weekly Profit Analysis & Weekly Market Pulse Alerts - Newser
What are the analyst revisions for ENTXIs Axogen Inc. stock a good investment in YEARWeekly Risk Summary & Weekly Return Optimization Alerts - khodrobank.com
Can technical indicators confirm Axogen Inc.’s reversalJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - Newser
Can Axogen Inc. hit a new high this monthJuly 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Is Axogen Inc. still worth holding after the dip2025 Macro Impact & Weekly Chart Analysis and Guides - Newser
Signal strength of Axogen Inc. stock in tech scanners2025 Geopolitical Influence & Stepwise Swing Trade Plans - Newser
Can Axogen Inc. sustain earnings growthWeekly Trend Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
How sensitive is Axogen Inc. to inflationJobs Report & Risk Managed Investment Signals - khodrobank.com
Levi & Korsinsky Investigates Axogen, Inc. (AXGN) Over Potential Securities Fraud Allegations - ACCESS Newswire
Is Axogen Inc. likely to announce a buybackQuarterly Earnings Report & Fast Gaining Stock Reports - khodrobank.com
ATTENTION Axogen, Inc. (AXGN) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Developing predictive dashboards with Axogen Inc. dataQuarterly Earnings Report & Technical Entry and Exit Alerts - Newser
What are Axogen Inc.’s recent SEC filings showingQuarterly Portfolio Summary & Technical Buy Zone Confirmation - khodrobank.com
Will Axogen Inc. outperform its industry peersWeekly Trend Recap & High Accuracy Investment Entry Signals - khodrobank.com
Axogen Inc.’s volatility index tracking explainedIndex Update & Free Growth Oriented Trading Recommendations - Newser
Historical volatility pattern of Axogen Inc. visualized2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
What chart patterns are forming on Axogen Inc.Earnings Growth Report & Weekly Setup with ROI Potential - khodrobank.com
What does recent volatility data suggest for Axogen Inc.Quarterly Trade Report & Precise Buy Zone Tips - Newser
Real time scanner hits for Axogen Inc. explainedBreakout Watch & Step-by-Step Swing Trade Plans - Newser
Key metrics from Axogen Inc.’s quarterly data2025 Volatility Report & Fast Entry and Exit Trade Plans - Newser
What high frequency data says about Axogen Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Can Axogen Inc. weather a recessionRate Hike & Weekly Breakout Opportunity Watchlist - khodrobank.com
Is Axogen Inc. a candidate for recovery playWeekly Profit Recap & Capital Efficiency Focused Ideas - Newser
Can Axogen Inc. grow without external fundingJuly 2025 Levels & Growth Focused Stock Reports - khodrobank.com
Sector ETF performance correlation with Axogen Inc.Portfolio Return Report & Smart Allocation Stock Tips - Newser
What is the earnings history of Axogen Inc.Watch List & Consistent Income Trade Recommendations - khodrobank.com
Technical signs of recovery in Axogen Inc.2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser
What data driven models say about Axogen Inc.’s futureTrade Exit Summary & Weekly Breakout Watchlists - Newser
Price momentum metrics for Axogen Inc. explainedTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Analyzing Axogen Inc. with risk reward ratio chartsEarnings Risk Summary & Weekly Top Gainers Alerts - Newser
Axogen Inc. Stock Approaches Key Moving AveragePortfolio Performance Summary & Fast Moving Market Watchlists - beatles.ru
What does recent volatility data suggest for Axogen IncStop Loss & Long-Term Growth Stock Strategies - Newser
Published on: 2025-08-31 19:47:00 - Newser
Why Axogen Inc. stock attracts strong analyst attentionProduct Launch & Reliable Price Action Trade Plans - Newser
Building trade automation scripts for Axogen Inc.Bond Market & Risk Controlled Swing Trade Alerts - Newser
How high can Axogen Inc. stock goQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Will Axogen Inc. bounce back from current supportQuarterly Portfolio Review & Consistent Growth Equity Picks - Newser
Institutional Ownership and Strategic Influence in Axogen, Inc. (NASDAQ:AXGN): A Double-Edged Sword for Shareholders - AInvest
Axogen's Ownership Structure: Institutional Dominance and Insider Sales - AInvest
With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners - uk.finance.yahoo.com
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Axogen Inc-Aktie (AXGN) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Levine Alan M | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
36,743 |
Wendell Amy McBride | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
93,826 |
Burke William P. Mr. | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,484 |
NEELS GUIDO J | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
86,743 |
JOHNSON JOHN | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,943 |
TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Option Exercise |
6.56 |
11,586 |
75,952 |
26,931 |
TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Sale |
10.72 |
26,931 |
288,700 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):